European Archives - Page 674 of 1227 - European Medical Journal

Hematology 9.1 Journal feature image

Glanzmann Thrombasthenia: A Case Report

Eduard Glanzmann first reported Glanzmann thrombasthenia (GT) in 1918 after he identified a functional abnormality of platelets with defective clot retraction.

Webinar: Treatment of Heart Failure in 2021: moving towards personalized approach?

This webinar dives into the treatment of heart failure in 2021. Chaired by Dr. Jonathan Sackier, it features presentations from a panel of renowned experts.

COVID-19 Immunity Delayed in Cancer Patients

Recent evidence has shown that cancer patients lack seropositivity following a single dose of the Pfizer-BioNTech mRNA COVID-19 vaccine. This urges the need for patients undergoing cancer treatment to be prioritised in the vaccine scheme, as their protection against the virus is delayed, relative to a healthy population.

Moderate Alcohol Consumption Linked to Higher Risk of Cancer Development

SURPRISING new evidence has emerged suggesting a strong link between alcohol consumption and an increased risk of developing certain cancers.

Reimagining patient care and future direction in Axial Spondyloarthritis and Psoriatic Arthritis

In this session chaired by Prof. Baraliakos, Prof. Nash and Prof. Machado discuss advances in artificial intelligence and machine learning that could potentially aid in the diagnosis and management of axSpA and PsA.

Reimagining the standard of care in Psoriatic Arthritis and Axial Spondyloarthritis

In this short summary video, Prof. Gottlieb discusses the role dermatologists can play in detecting PsA as well as the diagnostic tools that can be used to help achieve an early diagnosis.

Meet the expert: Managing Axial Psoriatic Arthritis

In this short summary video, Prof. Mease discusses the need for consensus on the definition and classification criteria for the axial manifestation of PsA, also highlighting the need for specific clinical assessments and clinical trials designed to investigate the efficacy of therapy options in this patient population.

LEO Pharma’s Monica Shaw on access to medicine challenges

Monica Shaw, Executive Vice President, Region EUROPE Plus, LEO Pharma, speaks with GOLD about digital transformation in healthcare

A New Prognosis for Multiple Sclerosis

We explore Professor Leigh Charvet’s vast research within multiple sclerosis, consider her time working in industry compared with her experiences in…

EMJ Podcast: Spotlight on Non-Small Cell Lung Cancer (NSCLC)

In this episode, Dr Marina Garassino explores the unmet needs for patients living with EGFR-mutated non-small cell lung cancer (NSCLC).